Federal Agency Retail Pharmacy Program

Forms and Documents

Document Name	Status
0720-0032_OMB Supporting Statement_ FINAL.DOC Supporting Statement A	2016-06-06

IC Document Collections

IC ID	Document Title	Status
5612	Federal Agency Retail Pharmacy Program Other-Online system	Modified

ICR Details

OMB Control No: 0720-0032	ICR Reference No: 201606-0720-001
Status: Historical Active	Previous ICR Reference No: 201301-0720-001
Agency/Subagency: DOD/DODOASHA	Agency Tracking No:
Title: Federal Agency Retail Pharmacy Program
Type of Information Collection: Revision of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 08/05/2016
	Date Received in OIRA: 06/06/2016
Terms of Clearance:

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	08/31/2019	36 Months From Approved	08/31/2016
Responses	1,200	0	2,000
Time Burden (Hours)	9,600	0	16,000
Cost Burden (Dollars)	403,968	0	0

---

Abstract: DoD is extending information collections requirements under current OMB Control Number 0720-0032. Pharmaceutical manufacturers will base refund calculation on difference between average non-Federal price of drug sold by pharmaceutical manufacturer to wholesalers, represented by most recent annual non-Federal average manufacturing prices (non-FAMP) and corresponding Federal Ceiling Price (FCP) or, at discretion of pharmaceutical manufacturer, difference between FCP and direct commercial contract sales price attributable to applicable National Drug Code.

---

Authorizing Statute(s): US Code: 10 USC 1074g(f) Name of Law: Pharmacy benefits program
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	80 FR 68301	11/04/2015
30-day Notice:	Federal Register Citation:	Citation Date:
	81 FR 36282	06/06/2016
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
Federal Agency Retail Pharmacy Program

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	1,200	2,000	0	-800	0	0
Annual Time Burden (Hours)	9,600	16,000	0	-6,400	0	0
Annual Cost Burden (Dollars)	403,968	0	0	403,968	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: Yes

Burden Reduction Due to: Cutting Redundancy

Short Statement: There has been an increase in the number of pharmaceutical manufacturers who have covered drugs eligible for the TRRP. Based upon analysis of the utilization data used in prior billings, DHA determined it needed to re-bill the 3rd Quarter Calendar Year (QCY) 2009 to 4th QCY 2011 utilization data during the last OMB renewal period. DHA does not anticipate that re-billing additional quarters will be necessary. As a result, this reduces the number of responses per respondent from 8 to 4 annually.

---

Annual Cost to Federal Government: $4,361,120

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 06/06/2016

---